Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

245
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
245
Prodrugs01:30

Prodrugs

4.1K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
4.1K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.2K
Drug Discovery: Overview01:26

Drug Discovery: Overview

11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry01:29

Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry

5.5K
Diels–Alder reactions between cyclic dienes locked in an s-cis configuration and dienophiles yield bridged bicyclic products.
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Same author

Tumor targeting by conjugation of DHA to paclitaxel.

Journal of controlled release : official journal of the Controlled Release Society·2001
Same author

Fusion of dipalmitoylphosphatidylcholine vesicles at 4 degrees C.

Biochemistry·1982
Same author

Modification of a vibrating-tube density meter for precise temperature scanning.

Analytical biochemistry·1981

Related Experiment Video

Updated: Jan 19, 2026

Author Spotlight: In Vitro and In Vivo Models to Enhance Chronic Pain Treatment Efficacy
06:56

Author Spotlight: In Vitro and In Vivo Models to Enhance Chronic Pain Treatment Efficacy

Published on: June 28, 2024

1.8K

New product opportunities with DRGs.

F H Anthony

    Hospital Pharmacy
    |December 11, 1984
    PubMed
    Summary

    New Medicare payment schemes and cost pressures are reducing hospital admissions. This creates opportunities for innovative, lower-cost medical devices and pharmaceuticals, particularly in outpatient care and less-invasive procedures.

    Area of Science:

    • Health Economics
    • Medical Device Innovation
    • Pharmaceutical Market Analysis

    Background:

    • Medicare's revised payment models and increasing cost-containment pressures are significantly altering hospital operations.
    • Declines in patient admission numbers and lengths of stay necessitate a reevaluation of hospital supply chain and service delivery strategies.

    Purpose of the Study:

    • To analyze the economic incentives shaping the current hospital market.
    • To identify emerging product opportunities for the device and pharmaceutical industries within this evolving landscape.
    • To illustrate these opportunities using specific product examples.

    Main Methods:

    • Analysis of Medicare's new payment structures and their economic implications for hospitals.
    • Identification of market trends driven by cost-containment and efficiency demands.

    More Related Videos

    The Chick Chorioallantoic Membrane In Vivo Model to Assess Perineural Invasion in Head and Neck Cancer
    09:16

    The Chick Chorioallantoic Membrane In Vivo Model to Assess Perineural Invasion in Head and Neck Cancer

    Published on: June 21, 2019

    16.1K
    Dorsal Root Ganglia Isolation and Primary Culture to Study Neurotransmitter Release
    08:15

    Dorsal Root Ganglia Isolation and Primary Culture to Study Neurotransmitter Release

    Published on: October 6, 2018

    52.6K

    Related Experiment Videos

    Last Updated: Jan 19, 2026

    Author Spotlight: In Vitro and In Vivo Models to Enhance Chronic Pain Treatment Efficacy
    06:56

    Author Spotlight: In Vitro and In Vivo Models to Enhance Chronic Pain Treatment Efficacy

    Published on: June 28, 2024

    1.8K
    The Chick Chorioallantoic Membrane In Vivo Model to Assess Perineural Invasion in Head and Neck Cancer
    09:16

    The Chick Chorioallantoic Membrane In Vivo Model to Assess Perineural Invasion in Head and Neck Cancer

    Published on: June 21, 2019

    16.1K
    Dorsal Root Ganglia Isolation and Primary Culture to Study Neurotransmitter Release
    08:15

    Dorsal Root Ganglia Isolation and Primary Culture to Study Neurotransmitter Release

    Published on: October 6, 2018

    52.6K
  • Case study approach examining product innovations from Rorer Group Inc.

    • Main Results:

    • Hospitals are prioritizing cost reduction, leading to decreased demand for traditional supplies.
    • New market conditions foster innovation in areas such as outpatient care, minimally invasive surgery, and reduced hospital stay durations.
    • Opportunities exist for products offering equivalent or improved quality of care at a lower cost.

    Conclusions:

    • The changing hospital economic environment presents significant opportunities for medical device and pharmaceutical companies.
    • Innovation focused on cost-effectiveness, outpatient solutions, and procedure efficiency is crucial for market success.
    • Rorer Group Inc.'s product development reflects an adaptation to these new hospital market needs.